)
Edge17 Oct 2025
A Castle in the Sky: The Story of Oracle
Oracle's journey from database innovator to disciplined enterprise backbone, now shaping the AI buildout with a standardized cloud infrastructure.
AngioDynamics (ANGO) investor relations material
AngioDynamics Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary2 Oct, 2025
Executive summary
Achieved 12.2% year-over-year revenue growth to $75.7 million, led by 26.1% Med Tech growth and 2.3% Med Device growth.
Med Tech segment sales reached $35.3 million, marking the fourth consecutive quarter of over 20% growth.
Adjusted EBITDA turned positive at $2.2 million, up from a loss in the prior year.
Ended the quarter with $38.8 million in cash and zero debt, providing financial flexibility.
Raised full-year FY26 guidance for net sales, Med Tech growth, Adjusted EBITDA, and Adjusted EPS.
Financial highlights
Med Tech revenue: $35.3 million (+26.1%); Med Device revenue: $40.4 million (+2.3%).
Gross margin improved to 55.3%, up 90 basis points year-over-year; Med Tech gross margin 62.2%, Med Device 49.3%.
Adjusted net loss narrowed to $4.2 million (loss per share $0.10); GAAP net loss was $10.9 million (loss per share $0.26).
Adjusted EBITDA for Q1 FY26 was $2.2 million, up from $(0.2) million in Q1 FY25.
Cash utilization for the quarter was $17.1 million, with cash and equivalents at $38.8 million and no debt.
Outlook and guidance
FY26 net sales guidance raised to $308–$313 million (5–7% growth over FY25).
Med Tech net sales expected to grow 14–16%; Med Device expected to be flat.
Gross margin guidance at 53.5–55.5%, including $4–$6 million in tariff impact.
Adjusted EBITDA guidance increased to $6–$10 million; adjusted loss per share improved to $0.33–$0.23.
Expects to be cash flow positive for full FY26.
Key drivers for Med Tech segment growth?
NanoKnife CPT I code and market strategy?
Mechanical Thrombectomy sales force impact?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next AngioDynamics earnings date
Q2 20267 Jan, 2026
Next AngioDynamics earnings date
Q2 20267 Jan, 2026
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research17 Oct 2025
Beneath the Surface: A Conversation with Epiroc CEO Helena Hedblom
Legacy, innovation, and leading one of Sweden's most influential industrial companies into a new era.
)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Frequently asked questions
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for use by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings in the United States and internationally. The company operates through four segments: Vascular Access, Peripheral Vascular, Oncology/Surgery, and Venous Therapies. The Peripheral Vascular segment primarily offers radiofrequency ablation systems to ablate or destroy undesired tissue; angiographic products to access the vasculature; thrombolytic products to treat clots; embolization products to block blood flow to a tumor; vena cava filters to trap clot before it can travel to the lungs; dialysis catheters used in hemodialysis procedures; and a range of products used in minimally-invasive, image-guided procedures.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage